氨甲酸,[1-甲酰基-3-(甲硫基)丙基]-,1,1-二甲基乙基酯 | 119927-71-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 氨甲酸,[1-甲酰基-3-(甲硫基)丙基]-,1,1-二甲基乙基酯
• 英文名称: tert-butyl (4-(methylthio)-1-oxobutan-2-yl)carbamate
• 英文别名: Carbamic acid, [1-formyl-3-(methylthio)propyl]-, 1,1-dimethylethyl ester；tert-butyl N-(4-methylsulfanyl-1-oxobutan-2-yl)carbamate
• CAS: 119927-71-8
• 化学式: C₁₀H₁₉NO₃S
• 分子量: 233.332
• InChiKey: AAJVCQPQGWUYMD-UHFFFAOYSA-N

物化性质

• 沸点：
  351.1±37.0 °C(Predicted)
• 密度：
  1.072±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  15
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  80.7
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  氨甲酸,[1-甲酰基-3-(甲硫基)丙基]-,1,1-二甲基乙基酯 在 三氟乙酸 作用下， 以 甲醇 、 1,2-二氯乙烷 为溶剂， 生成 2-Benzhydryl-3-benzyl-5-(2-methylsulfanyl-ethyl)-4,5-dihydro-3H-imidazole-4-carboxylic acid cyclohexylamide
  参考文献：
  名称：

  Remarkable three-step-one-pot solution phase preparation of novel imidazolines utilizing a UDC (Ugi/de-Boc/cyclize) strategy

  摘要：

  This communication reveals the novel solution phase synthesis of an array of biologically relevant imidazolines in a remarkable 'three-step-one-pot' procedure, utilizing a Ugi/de-Boc/cyclization (UDC) strategy. Transformations are carried out in excellent yield by condensation of N-Boc-alpha-amino-aldehydes and supporting Ugi reagents. The described protocol represents a highly attractive solution phase procedure for the rapid generation of this class of molecule. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4039(99)01580-4
• 作为产物：
  描述：

  2-(叔丁氧基羰基氨基)-4-(甲基硫代)丁酸 在 lithium aluminium tetrahydride 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 作用下， 以 四氢呋喃 、 吡啶 、 二氯甲烷 为溶剂， 生成 氨甲酸,[1-甲酰基-3-(甲硫基)丙基]-,1,1-二甲基乙基酯
  参考文献：
  名称：

  Remarkable three-step-one-pot solution phase preparation of novel imidazolines utilizing a UDC (Ugi/de-Boc/cyclize) strategy

  摘要：

  This communication reveals the novel solution phase synthesis of an array of biologically relevant imidazolines in a remarkable 'three-step-one-pot' procedure, utilizing a Ugi/de-Boc/cyclization (UDC) strategy. Transformations are carried out in excellent yield by condensation of N-Boc-alpha-amino-aldehydes and supporting Ugi reagents. The described protocol represents a highly attractive solution phase procedure for the rapid generation of this class of molecule. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4039(99)01580-4

文献信息

• Method of treating cancer
  申请人：——

  公开号：US20030220241A1

  公开（公告）日：2003-11-27

  The present invention relates to methods of treating cancer using a combination of a compound which is a PSA conjugate and a compound which is a inhibitor of prenyl-protein transferase, which methods comprise administering to said mammal, either sequentially in any order or simultaneously, amounts of at least two therapeutic agents selected from a group consisting of a compound which is a PSA conjugate and a compound which is a inhibitor of prenyl-protein transferase. The invention also relates to methods of preparing such compositions.

  本发明涉及使用一种PSA共轭物和一种前脂蛋白转移酶抑制剂的组合治疗癌症的方法，该方法包括向所述哺乳动物施用来自以下组中选择的至少两种治疗剂的量，所述组包括一种PSA共轭物和一种前脂蛋白转移酶抑制剂，所述治疗剂可以顺序给药或同时给药。该发明还涉及制备这种组合物的方法。
• A rapid and efficient one-pot method for the reduction of N-protected α-amino acids to chiral α-amino aldehydes using CDI/DIBAL-H
  作者：Jakov Ivkovic、Christian Lembacher-Fadum、Rolf Breinbauer

  DOI：10.1039/c5ob01838b

  日期：——

  N-Protected α-amino acids can be easily converted directly into chiral α-amino aldehydes in a one-pot procedure by activation with CDI followed by reduction with DIBAL-H.

  N-保护的α-氨基酸可以通过使用CDI激活后再用DIBAL-H还原，在一个步骤中轻松直接转化为手性α-氨基醛。
• AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS
  申请人：Connor Eric

  公开号：US20140356316A1

  公开（公告）日：2014-12-04

  The present invention provides crosslinked amine polymers effective for binding and removing bile salts from the gastrointestinal tract. These bile acid binding polymers or pharmaceutical compositions thereof can be administered to subjects to treat various conditions, including hypercholesteremia, diabetes, pruritus, irritable bowel syndrome-diarrhea (IBS-D), bile acid malabsorption, and the like.

  本发明提供了交联胺聚合物，用于有效地结合和清除胆盐从胃肠道。这些胆酸结合聚合物或其药物组合物可以被用于治疗各种疾病，包括高胆固醇血症、糖尿病、瘙痒、肠易激综合征-腹泻（IBS-D）、胆酸吸收不良等。
• Synthesis of Fused Heteroarylprolines and Pyrrolopyrroles
  作者：Guillaume Jeannotte、William D. Lubell

  DOI：10.1021/jo049612i

  日期：2004.7.1

  the selective deprotection and alkylation of the pyrrole nitrogen of pyrroloprolines 17 were developed to expand the diversity of the heteoaryl systems. Finally, hydrogenolytic cleavage of the PhF and benzyl groups followed by subsequent protection with Boc, Fmoc, and Moz groups was performed to obtain analogues suitable for peptide synthesis. The enantiomeric purity of N-(Boc)pyrrolo-proline 21a was

  按照以下两种方法，从4-氧代-N-（PhF）脯氨酸苄基酯（6，PhF = 9-（9-苯基芴基））制备熔融的杂芳基脯氨酸。首先，羟脯氨酸6的烯丙基化，然后进行Wacker氧化，得到1,4-二酮8，该1,4-二酮8被选择性地转化为吡咯啉脯氨酸10b，吡咯并吡咯12和哒嗪基脯氨酸9。第二，氧代脯氨酸6与一系列N-（Boc）-α-氨基醛15a - e的醛醇缩合和酸催化的环化反应得到吡咯啉脯氨酸17a - e具有各种吡咯5位取代基。开发了吡咯脯氨酸17的吡咯氮的选择性脱保护和烷基化条件，以扩大杂芳基系统的多样性。最后，进行PhF和苄基的氢解裂解，随后用Boc，Fmoc和Moz基团进行保护以获得适合于肽合成的类似物。N-（Boc）吡咯并脯氨酸21a的对映体纯度是通过与l-和d偶联来确定的-苯丙氨酸甲酯和非对映体吡咯质子的检查，证明二肽的非对映体纯度> 99％。因此，这些方法提供了第一批对映体纯的稠合芳
• [EN] A METHOD OF TREATING ENDOMETRIOSIS<br/>[FR] PROCEDE POUR TRAITER L'ENDOMETRIOSE
  申请人：MERCK & CO INC

  公开号：WO2000025789A1

  公开（公告）日：2000-05-11

  A method of preventing and treating endometriosis, uterine fibroids, dysfunctional uterine bleeding and endometrial hyperplasia is disclosed which is comprised of administering to a mammalian patient in need of such treatment an effective amount of a prenyl-protein transferase inhibitor.

  本发明揭示了一种预防和治疗子宫内膜异位症、子宫肌瘤、功能性子宫出血和子宫内膜增生的方法，包括向需要此类治疗的哺乳动物患者投予有效量的戊二酰基-蛋白转移酶抑制剂。